ATC code G
ATC code G Genito-urinary system and sex hormones is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
G Genito-urinary system and sex hormones |
---|
G01 Gynecological antiinfectives and antiseptics |
G02 Other gynecologicals |
G03 Sex hormones and modulators of the genital system |
G04 Urologicals |
ATCvet only |
QG51 Antiinfectives and antiseptics for intrauterine use |
QG52 Products for teats and udder |
|
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code G". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QG". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) |
|
|
Antibiotics | |||||||||
---|---|---|---|---|---|---|---|---|---|
Arsenic compounds | |||||||||
Quinoline derivatives | |||||||||
Organic acids | |||||||||
Sulfonamides | |||||||||
Antifungals |
| ||||||||
Other |
Cervical ripening |
| ||||
---|---|---|---|---|---|
Contraction induction |
| ||||
|
Comparison | |||||
---|---|---|---|---|---|
Behavioral |
| ||||
Barrier and / or spermicidal | |||||
Hormonal (formulations) |
| ||||
Anti-estrogen |
| ||||
Post-intercourse |
| ||||
Intrauterine device | |||||
Sterilization |
| ||||
Experimental | |||||
Long-acting reversible contraception (LARC) |
Tocolytics/labor repressants (G02CA) | |
---|---|
β2 adrenoreceptor agonists |
|
Oxytocin antagonists | |
NSAIDs | |
Calcium channel blockers | |
Myosin inhibitors |
|
Prolactin inhibitors | |
---|---|
Anti-inflammatory products for vaginal administration |
Estrogens |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Antiestrogens |
| ||||||||
|
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
GnRH and gonadotropins | |||||
---|---|---|---|---|---|
GnRH modulators (incl. analogues) |
| ||||
Gonadotropins |
| ||||
Others (indirect) |
| ||||
|
Urologicals, including antispasmodics (G04B) | |
---|---|
Acidifiers |
|
Urinary antispasmodics (primarily antimuscarinics) | |
Other urologicals |
|
For erectile dysfunction |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
For premature ejaculation |
| ||||||||||||
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.